 Sondra Bland
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Isolation | 5 | 2017 | 61 | 2.570 |
Why?
| | Prefrontal Cortex | 10 | 2017 | 275 | 1.910 |
Why?
| | Nucleus Accumbens | 7 | 2014 | 131 | 1.460 |
Why?
| | Morphine | 9 | 2009 | 132 | 1.310 |
Why?
| | Dopamine | 8 | 2014 | 249 | 1.250 |
Why?
| | Proto-Oncogene Proteins c-fos | 9 | 2017 | 193 | 1.200 |
Why?
| | Rats, Sprague-Dawley | 30 | 2020 | 2434 | 1.170 |
Why?
| | Neuroglia | 5 | 2017 | 155 | 1.090 |
Why?
| | Serotonin | 10 | 2014 | 308 | 0.960 |
Why?
| | Rats | 34 | 2020 | 5339 | 0.890 |
Why?
| | Motor Activity | 11 | 2017 | 664 | 0.890 |
Why?
| | Interpersonal Relations | 2 | 2016 | 342 | 0.800 |
Why?
| | Fear | 5 | 2020 | 306 | 0.800 |
Why?
| | Neurons | 8 | 2017 | 1340 | 0.770 |
Why?
| | Social Behavior | 3 | 2020 | 275 | 0.770 |
Why?
| | Stress, Psychological | 10 | 2009 | 967 | 0.760 |
Why?
| | Aggression | 3 | 2016 | 184 | 0.730 |
Why?
| | Stress, Physiological | 6 | 2007 | 414 | 0.720 |
Why?
| | Conditioning, Classical | 1 | 2020 | 89 | 0.710 |
Why?
| | Escherichia coli Infections | 2 | 2010 | 105 | 0.680 |
Why?
| | Monoacylglycerol Lipases | 1 | 2017 | 1 | 0.640 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2007 | 90 | 0.630 |
Why?
| | Behavior, Animal | 13 | 2020 | 486 | 0.630 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2012 | 117 | 0.620 |
Why?
| | Narcotics | 5 | 2009 | 49 | 0.620 |
Why?
| | Sex Characteristics | 4 | 2017 | 667 | 0.600 |
Why?
| | Cocaine | 3 | 2014 | 158 | 0.530 |
Why?
| | Microdialysis | 11 | 2014 | 65 | 0.530 |
Why?
| | Raphe Nuclei | 6 | 2005 | 118 | 0.510 |
Why?
| | Electroshock | 10 | 2007 | 150 | 0.490 |
Why?
| | Hippocampus | 6 | 2017 | 735 | 0.490 |
Why?
| | Forelimb | 4 | 2001 | 29 | 0.490 |
Why?
| | Brain | 4 | 2020 | 2481 | 0.470 |
Why?
| | Animals | 40 | 2020 | 33152 | 0.470 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2014 | 53 | 0.470 |
Why?
| | Central Nervous System Stimulants | 3 | 2010 | 142 | 0.460 |
Why?
| | Social Perception | 1 | 2014 | 98 | 0.440 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 54 | 0.430 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2020 | 369 | 0.430 |
Why?
| | RNA, Messenger | 6 | 2010 | 2657 | 0.410 |
Why?
| | Analysis of Variance | 10 | 2016 | 1288 | 0.410 |
Why?
| | Amphetamine | 1 | 2010 | 23 | 0.370 |
Why?
| | Male | 39 | 2020 | 57474 | 0.350 |
Why?
| | Central Nervous System Infections | 1 | 2009 | 38 | 0.340 |
Why?
| | Cell Count | 7 | 2012 | 315 | 0.310 |
Why?
| | Analgesics, Opioid | 4 | 2012 | 789 | 0.300 |
Why?
| | Grooming | 2 | 2017 | 7 | 0.300 |
Why?
| | Cognition | 2 | 2017 | 1026 | 0.300 |
Why?
| | Weaning | 2 | 2017 | 57 | 0.290 |
Why?
| | Dose-Response Relationship, Drug | 8 | 2017 | 1937 | 0.290 |
Why?
| | Immunohistochemistry | 8 | 2015 | 1681 | 0.280 |
Why?
| | Animals, Newborn | 3 | 2016 | 804 | 0.270 |
Why?
| | Pyridines | 1 | 2009 | 436 | 0.260 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2001 | 41 | 0.250 |
Why?
| | Corpus Striatum | 3 | 2017 | 127 | 0.250 |
Why?
| | Motor Cortex | 2 | 2005 | 52 | 0.240 |
Why?
| | Conditioning, Operant | 4 | 2012 | 103 | 0.240 |
Why?
| | Membrane Proteins | 1 | 2010 | 1048 | 0.240 |
Why?
| | Cytokines | 1 | 2010 | 1880 | 0.210 |
Why?
| | Stem Cells | 1 | 2006 | 556 | 0.200 |
Why?
| | Rats, Long-Evans | 5 | 2020 | 105 | 0.200 |
Why?
| | Glutamic Acid | 2 | 1999 | 223 | 0.200 |
Why?
| | Escape Reaction | 4 | 2016 | 68 | 0.190 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2009 | 482 | 0.190 |
Why?
| | Neuropsychological Tests | 3 | 2006 | 1027 | 0.190 |
Why?
| | Weight-Bearing | 1 | 2001 | 172 | 0.190 |
Why?
| | Cerebral Decortication | 1 | 2000 | 1 | 0.190 |
Why?
| | Parkinsonian Disorders | 1 | 2000 | 29 | 0.180 |
Why?
| | Extinction, Psychological | 1 | 2020 | 81 | 0.180 |
Why?
| | Ischemic Attack, Transient | 1 | 2000 | 62 | 0.170 |
Why?
| | Random Allocation | 2 | 2017 | 344 | 0.160 |
Why?
| | Physical Conditioning, Animal | 1 | 2020 | 204 | 0.160 |
Why?
| | Naloxone | 3 | 2012 | 98 | 0.160 |
Why?
| | Succinimides | 1 | 2017 | 17 | 0.160 |
Why?
| | Bromodeoxyuridine | 2 | 2009 | 76 | 0.160 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2010 | 86 | 0.160 |
Why?
| | Helplessness, Learned | 3 | 2009 | 64 | 0.160 |
Why?
| | Carbamates | 1 | 2017 | 37 | 0.160 |
Why?
| | Emotions | 2 | 2017 | 494 | 0.150 |
Why?
| | Narcotic Antagonists | 3 | 2012 | 136 | 0.150 |
Why?
| | Glucocorticoids | 3 | 2007 | 545 | 0.150 |
Why?
| | Transforming Growth Factor beta | 1 | 2000 | 461 | 0.150 |
Why?
| | AIDS-Related Complex | 1 | 2016 | 4 | 0.150 |
Why?
| | Spinal Cord Injuries | 1 | 2000 | 184 | 0.150 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2016 | 18 | 0.150 |
Why?
| | Norepinephrine | 2 | 2009 | 212 | 0.140 |
Why?
| | Gene Expression Regulation | 7 | 2012 | 2435 | 0.140 |
Why?
| | Recovery of Function | 1 | 2000 | 603 | 0.140 |
Why?
| | Female | 8 | 2020 | 61261 | 0.140 |
Why?
| | Enzyme Inhibitors | 2 | 2017 | 817 | 0.130 |
Why?
| | Microinjections | 5 | 2008 | 83 | 0.130 |
Why?
| | Interleukin-1beta | 2 | 2007 | 377 | 0.130 |
Why?
| | Tail | 4 | 2007 | 33 | 0.130 |
Why?
| | Cell Survival | 2 | 2009 | 1045 | 0.120 |
Why?
| | Neural Pathways | 2 | 2006 | 277 | 0.120 |
Why?
| | Exploratory Behavior | 1 | 2014 | 89 | 0.120 |
Why?
| | Space Perception | 1 | 2014 | 65 | 0.120 |
Why?
| | Psychological Tests | 1 | 2014 | 127 | 0.110 |
Why?
| | Reward | 4 | 2008 | 209 | 0.110 |
Why?
| | Gene Expression | 2 | 2010 | 1482 | 0.110 |
Why?
| | Locus Coeruleus | 2 | 2009 | 21 | 0.100 |
Why?
| | Drug Administration Schedule | 3 | 2009 | 734 | 0.100 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 108 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 189 | 0.100 |
Why?
| | Cues | 1 | 2014 | 297 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2012 | 307 | 0.100 |
Why?
| | Stroke | 1 | 2000 | 1046 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2012 | 218 | 0.100 |
Why?
| | Dominance, Cerebral | 2 | 2001 | 52 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2009 | 2262 | 0.090 |
Why?
| | Corticosterone | 3 | 2007 | 253 | 0.090 |
Why?
| | CD11b Antigen | 1 | 2010 | 57 | 0.090 |
Why?
| | Antimetabolites | 1 | 2009 | 25 | 0.090 |
Why?
| | Electric Stimulation | 2 | 2009 | 268 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 330 | 0.090 |
Why?
| | Somatosensory Cortex | 2 | 2000 | 37 | 0.090 |
Why?
| | Volition | 1 | 2009 | 33 | 0.090 |
Why?
| | Amygdala | 2 | 2017 | 175 | 0.090 |
Why?
| | Morphine Dependence | 1 | 2009 | 3 | 0.090 |
Why?
| | Cytoskeletal Proteins | 1 | 2010 | 146 | 0.090 |
Why?
| | Neuronal Plasticity | 2 | 2001 | 219 | 0.080 |
Why?
| | Minocycline | 1 | 2008 | 28 | 0.080 |
Why?
| | Prostaglandins | 1 | 2007 | 78 | 0.080 |
Why?
| | Time Factors | 7 | 2012 | 6368 | 0.080 |
Why?
| | Analgesia | 1 | 2008 | 81 | 0.080 |
Why?
| | Antigens, CD | 1 | 2010 | 457 | 0.080 |
Why?
| | RNA, Antisense | 1 | 2007 | 19 | 0.080 |
Why?
| | Up-Regulation | 2 | 2009 | 862 | 0.070 |
Why?
| | Pain | 3 | 2008 | 736 | 0.070 |
Why?
| | Dentate Gyrus | 1 | 2006 | 32 | 0.070 |
Why?
| | Immunocompetence | 1 | 2006 | 43 | 0.070 |
Why?
| | Gyrus Cinguli | 1 | 2006 | 68 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 157 | 0.070 |
Why?
| | Meninges | 1 | 2006 | 31 | 0.070 |
Why?
| | Oxycodone | 1 | 2007 | 45 | 0.070 |
Why?
| | Neuroimmunomodulation | 1 | 2006 | 71 | 0.070 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2006 | 33 | 0.070 |
Why?
| | Central Nervous System Depressants | 1 | 2007 | 89 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 548 | 0.070 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 857 | 0.070 |
Why?
| | Estrous Cycle | 1 | 2005 | 17 | 0.070 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2004 | 4 | 0.060 |
Why?
| | Serotonin Agents | 1 | 2004 | 9 | 0.060 |
Why?
| | Electrochemistry | 1 | 2004 | 68 | 0.060 |
Why?
| | Adrenalectomy | 1 | 2004 | 79 | 0.060 |
Why?
| | Respiratory Insufficiency | 1 | 2008 | 289 | 0.060 |
Why?
| | Psychomotor Performance | 2 | 2007 | 289 | 0.060 |
Why?
| | Brain Chemistry | 1 | 2004 | 118 | 0.060 |
Why?
| | Injections, Intraventricular | 1 | 2004 | 73 | 0.060 |
Why?
| | Atrophy | 2 | 2001 | 164 | 0.060 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2004 | 77 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2006 | 497 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 2990 | 0.050 |
Why?
| | Adaptation, Psychological | 1 | 2006 | 545 | 0.050 |
Why?
| | Restraint, Physical | 3 | 2007 | 94 | 0.050 |
Why?
| | Ethanol | 1 | 2007 | 574 | 0.050 |
Why?
| | Functional Laterality | 2 | 2000 | 208 | 0.050 |
Why?
| | Phenotype | 1 | 2009 | 2937 | 0.050 |
Why?
| | Drug Interactions | 3 | 2008 | 351 | 0.050 |
Why?
| | Cerebral Cortex | 2 | 2001 | 415 | 0.050 |
Why?
| | Bone Morphogenetic Protein 7 | 1 | 2000 | 10 | 0.050 |
Why?
| | Oxidopamine | 1 | 2000 | 13 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2000 | 3676 | 0.050 |
Why?
| | Phosphorylation | 2 | 2017 | 1622 | 0.050 |
Why?
| | Evaluation Studies as Topic | 1 | 2000 | 181 | 0.050 |
Why?
| | Sex Factors | 1 | 2005 | 1765 | 0.040 |
Why?
| | Neck | 1 | 2000 | 89 | 0.040 |
Why?
| | Brain Damage, Chronic | 1 | 1999 | 24 | 0.040 |
Why?
| | Dizocilpine Maleate | 1 | 1999 | 16 | 0.040 |
Why?
| | Sirolimus | 1 | 2020 | 195 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2000 | 137 | 0.040 |
Why?
| | Dendrites | 1 | 2000 | 88 | 0.040 |
Why?
| | Corpus Callosum | 1 | 1999 | 57 | 0.040 |
Why?
| | Head Injuries, Closed | 1 | 1999 | 55 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 113 | 0.040 |
Why?
| | Memory | 1 | 2020 | 230 | 0.040 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2009 | 70 | 0.040 |
Why?
| | Reaction Time | 2 | 2012 | 390 | 0.040 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 1999 | 191 | 0.040 |
Why?
| | Muscimol | 2 | 2008 | 22 | 0.040 |
Why?
| | GABA Agonists | 2 | 2008 | 19 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2017 | 245 | 0.040 |
Why?
| | Brain Ischemia | 1 | 2000 | 309 | 0.040 |
Why?
| | Amino Acids | 1 | 1999 | 462 | 0.030 |
Why?
| | Hypothalamus | 1 | 2017 | 155 | 0.030 |
Why?
| | Injections, Subcutaneous | 2 | 2007 | 139 | 0.030 |
Why?
| | Brain Injuries | 1 | 1999 | 479 | 0.030 |
Why?
| | Signal Transduction | 2 | 2020 | 4688 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 42 | 0.030 |
Why?
| | Pain Threshold | 1 | 2012 | 69 | 0.030 |
Why?
| | Self Administration | 1 | 2012 | 125 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 95 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2012 | 108 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 173 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1202 | 0.020 |
Why?
| | Avoidance Learning | 1 | 2009 | 64 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2009 | 303 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2008 | 22 | 0.020 |
Why?
| | Spatial Behavior | 1 | 2008 | 22 | 0.020 |
Why?
| | Picrotoxin | 1 | 2008 | 14 | 0.020 |
Why?
| | GABA-A Receptor Agonists | 1 | 2008 | 11 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2008 | 16 | 0.020 |
Why?
| | GABA Antagonists | 1 | 2008 | 33 | 0.020 |
Why?
| | Naproxen | 1 | 2007 | 12 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1434 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2012 | 0.020 |
Why?
| | Dinoprostone | 1 | 2007 | 193 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2007 | 167 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 1969 | 0.020 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2006 | 57 | 0.020 |
Why?
| | Microglia | 1 | 2008 | 220 | 0.020 |
Why?
| | Pain Measurement | 1 | 2008 | 468 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 980 | 0.020 |
Why?
| | Oncogene Proteins v-fos | 1 | 2005 | 13 | 0.020 |
Why?
| | Reinforcement Schedule | 1 | 2005 | 30 | 0.020 |
Why?
| | Metyrapone | 1 | 2004 | 7 | 0.020 |
Why?
| | Afferent Pathways | 1 | 2005 | 44 | 0.020 |
Why?
| | Aminoglutethimide | 1 | 2004 | 8 | 0.020 |
Why?
| | Hormone Antagonists | 1 | 2004 | 40 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1082 | 0.020 |
Why?
| | Urocortins | 1 | 2004 | 20 | 0.020 |
Why?
| | Serotonin 5-HT1 Receptor Antagonists | 1 | 2003 | 3 | 0.010 |
Why?
| | Electrolysis | 1 | 2003 | 4 | 0.010 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2003 | 10 | 0.010 |
Why?
| | Spinal Cord | 1 | 2006 | 367 | 0.010 |
Why?
| | Extracellular Space | 1 | 2004 | 127 | 0.010 |
Why?
| | Hydrocortisone | 1 | 2004 | 272 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2693 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1623 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2004 | 294 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4044 | 0.010 |
Why?
| | Dichotic Listening Tests | 1 | 1999 | 7 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 700 | 0.010 |
Why?
| | Mice | 1 | 2012 | 15446 | 0.010 |
Why?
| | Brain Mapping | 1 | 1999 | 530 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 1999 | 3169 | 0.000 |
Why?
| | Humans | 2 | 2007 | 118251 | 0.000 |
Why?
| | Adolescent | 1 | 1999 | 18364 | 0.000 |
Why?
| | Child | 1 | 1999 | 19033 | 0.000 |
Why?
| | Adult | 1 | 1999 | 31324 | 0.000 |
Why?
|
|
Bland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|